Sorafenib, a multikinase inhibitor used for the treatment of hepatocellular carcinoma, is limited by its low oral bioavailability. To overcome this drawback, we have developed novel camel milk casein-derived nanoparticles as drug delivery system. Camel casein not only biocompatible on administration but actually dietary protein pharmaceutical relevance. Casein because amphiphilic nature, self-a...
